Eli Lilly patient assistance programs — looking for input

Dr.RheumBOS said:

My insurance denied my PA related to cost and coverage.

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

From the other side of the consultation, briefly.

Financial impact of cost and coverage weight loss beyond medication cost:

• Groceries: SAVED $230/month (eating less)
• Restaurants: SAVED $160/month (fewer meals out)
• Alcohol: SAVED $110/month (stopped drinking)
• Life insurance: Premium REDUCED by $40/month (lower BMI)
• Copays: SAVED $60/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

Dr.ReproEndo said:

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives: Prior authorization appeal…

Dr.ReproEndo said:

...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

pam_stl said:

Denials are usually procedural rather than clinical, and the order that works reflects that.

pam_stl said:

...my insurance denied cost and coverage coverage because...

Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:

1. Document medical necessity (BMI, comorbidities, failed alternatives)
2. Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
3. Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
4. Request peer-to-peer review between your doctor and the plan's medical director
5. File external appeal with your state insurance department if internal appeal fails

Don't accept the first denial. The appeal process exists for a reason.

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Tagging this one for the weekly digest.